carbamates has been researched along with Diabetes Mellitus in 36 studies
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to investigate the use of the short-acting insulin secretion drug repaglinide in new-onset diabetes mellitus (NODM) after renal transplantation." | 9.12 | Repaglinide in the management of new-onset diabetes mellitus after renal transplantation. ( Dolff, S; Heemann, U; Janssen, OE; Kribben, A; Mann, K; Philipp, T; Pietruck, F; Türk, T; Witzke, O, 2006) |
| "To report a case of clinically significant hypoglycemia attributed to the concomitant use of trimethoprim/sulfamethoxazole (TMP/SMX) and repaglinide by a diabetic patient." | 7.76 | Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient. ( Blondel, E; Fonrose, X; Mallaret, MP; Roustit, M; Villier, C, 2010) |
| "Insulin and glucose levels in response to premeal insulin lispro or repaglinide were evaluated in adult patients with cystic fibrosis-related diabetes (CFRD) without fasting hyperglycemia." | 7.71 | Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. ( Milla, C; Moran, A; Phillips, J, 2001) |
| "Repaglinide was administered with the dosage of 0." | 5.62 | Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports. ( Larijani, B; Mohammad Amoli, M; Nourbakhsh, M; Razzaghy-Azar, M; Talea, A, 2021) |
| "The purpose of this study was to investigate the use of the short-acting insulin secretion drug repaglinide in new-onset diabetes mellitus (NODM) after renal transplantation." | 5.12 | Repaglinide in the management of new-onset diabetes mellitus after renal transplantation. ( Dolff, S; Heemann, U; Janssen, OE; Kribben, A; Mann, K; Philipp, T; Pietruck, F; Türk, T; Witzke, O, 2006) |
| " Four trials (200 participants) are included: one short-term single-center trial (n = 7) comparing insulin with oral repaglinide and no medication in people with cystic fibrosis-related diabetes and normal fasting glucose; one long-term multicenter trial (n = 100, 74 of whom had cystic fibrosis-related diabetes) comparing insulin with oral repaglinide and placebo; one long-term multicenter trial (n = 73) comparing insulin with oral repaglinide; and one 12-week single-center trial (n = 20) comparing the long-acting insulin glargine to short-term neutral protamine Hagedorn insulin." | 4.93 | Insulin and oral agents for managing cystic fibrosis-related diabetes. ( Onady, GM; Stolfi, A, 2016) |
| "To report a case of clinically significant hypoglycemia attributed to the concomitant use of trimethoprim/sulfamethoxazole (TMP/SMX) and repaglinide by a diabetic patient." | 3.76 | Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient. ( Blondel, E; Fonrose, X; Mallaret, MP; Roustit, M; Villier, C, 2010) |
| "Insulin and glucose levels in response to premeal insulin lispro or repaglinide were evaluated in adult patients with cystic fibrosis-related diabetes (CFRD) without fasting hyperglycemia." | 3.71 | Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. ( Milla, C; Moran, A; Phillips, J, 2001) |
| "Repaglinide was administered with the dosage of 0." | 1.62 | Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports. ( Larijani, B; Mohammad Amoli, M; Nourbakhsh, M; Razzaghy-Azar, M; Talea, A, 2021) |
| " In fat tissues, the key genes Lep, Nmb and Nmbr were altered in high dosed offspring, and were differentially expressed between sexes." | 1.48 | Effects on metabolic parameters in young rats born with low birth weight after exposure to a mixture of pesticides. ( Axelstad, M; Christiansen, S; Hass, U; Mandrup, K; Ramhøj, L; Svingen, T; Vinggaard, AM, 2018) |
| "Repaglinide is a suitable agent for first-line monotherapy in patients whose glucose metabolism cannot be optimally controlled by increasing physical activity and appropriate dietary measures." | 1.31 | [Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients]. ( Landgraf, R, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (25.00) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 8 (22.22) | 29.6817 |
| 2010's | 11 (30.56) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Razzaghy-Azar, M | 1 |
| Nourbakhsh, M | 2 |
| Talea, A | 1 |
| Mohammad Amoli, M | 1 |
| Larijani, B | 1 |
| Patel, J | 1 |
| Maiti, S | 1 |
| Moorthy, NSHN | 1 |
| Onady, GM | 2 |
| Stolfi, A | 2 |
| Svingen, T | 1 |
| Ramhøj, L | 1 |
| Mandrup, K | 1 |
| Christiansen, S | 1 |
| Axelstad, M | 1 |
| Vinggaard, AM | 1 |
| Hass, U | 1 |
| Jabeen, S | 1 |
| Rashid, O | 1 |
| Furqan, S | 1 |
| Wan, M | 1 |
| Wang, Y | 1 |
| Zhan, L | 1 |
| Fan, J | 1 |
| Hu, TY | 1 |
| Gillery, P | 1 |
| Jaisson, S | 1 |
| Pombo, M | 1 |
| Olalla, J | 1 |
| Del Arco, A | 1 |
| De La Torre, J | 1 |
| Urdiales, D | 1 |
| Aguilar, A | 1 |
| Prada, JL | 1 |
| García-Alegría, J | 1 |
| Ruiz-Mateas, F | 1 |
| Ballmann, M | 1 |
| Hubert, D | 1 |
| Assael, BM | 1 |
| Kronfeld, K | 1 |
| Honer, M | 1 |
| Holl, RW | 1 |
| Zeltz, C | 1 |
| Gullberg, D | 1 |
| Roustit, M | 1 |
| Blondel, E | 1 |
| Villier, C | 1 |
| Fonrose, X | 1 |
| Mallaret, MP | 1 |
| Uchida, A | 1 |
| Moffa, P | 1 |
| Hueb, W | 1 |
| Cesar, LA | 1 |
| Ferreira, BM | 1 |
| Ramires, JA | 1 |
| Kreis, J | 1 |
| Busse, R | 1 |
| Feng, L | 1 |
| Zhu, M | 1 |
| Zhang, M | 1 |
| Jia, X | 1 |
| Cheng, X | 1 |
| Ding, S | 1 |
| Zhu, Q | 1 |
| Bleskestad, IH | 1 |
| Birkeland, KI | 1 |
| SCHWARTZ, W | 1 |
| Niemi, M | 1 |
| Kajosaari, LI | 1 |
| Neuvonen, M | 1 |
| Backman, JT | 1 |
| Neuvonen, PJ | 1 |
| Türk, T | 1 |
| Pietruck, F | 1 |
| Dolff, S | 1 |
| Kribben, A | 1 |
| Janssen, OE | 1 |
| Mann, K | 1 |
| Philipp, T | 1 |
| Heemann, U | 1 |
| Witzke, O | 1 |
| Oimomi, M | 1 |
| Ishikawa, K | 1 |
| Kawasaki, T | 1 |
| Kubota, S | 1 |
| Yoshimura, Y | 1 |
| Baba, S | 1 |
| Davenport, A | 1 |
| Jones, S | 1 |
| Goel, S | 1 |
| Astley, JP | 1 |
| Feest, TG | 1 |
| Mooradian, AD | 1 |
| Thurman, JE | 1 |
| Mozersky, RP | 1 |
| Landgraf, R | 1 |
| Carlton, FB | 1 |
| Moran, A | 1 |
| Phillips, J | 1 |
| Milla, C | 1 |
| Pospísilová, Y | 1 |
| Koivisto, V | 1 |
| Semichastnova, AG | 1 |
| Golubiatnikova, GA | 1 |
| Permiakov, NK | 1 |
| Titova, GP | 1 |
| Bokaneva, IA | 1 |
| Schein, PS | 1 |
| Alberti, KG | 1 |
| Williamson, DH | 1 |
| Herrman, JL | 1 |
| Nordlie, RC | 1 |
| Notarbartolo, A | 1 |
| Rini, GB | 1 |
| Di Fede, G | 1 |
| Garg, HG | 1 |
| Prakash, C | 1 |
| Mackerer, CR | 1 |
| Paquet, RJ | 1 |
| Mehlman, MA | 1 |
| Tobin, RB | 1 |
| Blickens, DA | 1 |
| Riggi, SJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open Randomised Prospective Comparative Multi-centre Intervention Study of Patients With Cystic Fibrosis and Early Diagnosed Diabetes Mellitus[NCT00662714] | Phase 3 | 73 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics[NCT00065676] | Phase 2 | 24 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for carbamates and Diabetes Mellitus
| Article | Year |
|---|---|
Drug treatments for managing cystic fibrosis-related diabetes.
Topics: Administration, Oral; Bias; Blood Glucose; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Fasting; | 2020 |
Post-translational modification derived products (PTMDPs): toxins in chronic diseases?
Topics: Carbamates; Diabetes Mellitus; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Li | 2014 |
Post-translational modifications of integrin ligands as pathogenic mechanisms in disease.
Topics: Amidohydrolases; Carbamates; Cell Adhesion; Diabetes Mellitus; Extracellular Matrix Proteins; Fibron | 2014 |
Insulin and oral agents for managing cystic fibrosis-related diabetes.
Topics: Administration, Oral; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Humans; Hyperglycemia; Hypogly | 2016 |
Drug therapy of postprandial hyperglycaemia.
Topics: 1-Deoxynojirimycin; Acarbose; Amyloid; Carbamates; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine | 1999 |
Recent advances in the pharmacologic management of diabetes mellitus.
Topics: Acarbose; Administration, Oral; Carbamates; Chromans; Diabetes Mellitus; Drug Overdose; Emergencies; | 2000 |
[News in oral antidiabetic therapy].
Topics: Administration, Oral; Carbamates; Diabetes Mellitus; Humans; Hypoglycemic Agents; Pioglitazone; Pipe | 2001 |
[Insulin analogs and new oral antidiabetic drugs].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Dose-Response Relationship, Drug; | 1999 |
4 trials available for carbamates and Diabetes Mellitus
| Article | Year |
|---|---|
Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
Topics: Adolescent; Algorithms; Carbamates; Child; Cystic Fibrosis; Diabetes Mellitus; Early Diagnosis; Huma | 2014 |
The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biotransformation; Carbamates; Cross-Over Studies; Cytochrome | 2004 |
Repaglinide in the management of new-onset diabetes mellitus after renal transplantation.
Topics: Carbamates; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Kidney Transplantation; Male; Mi | 2006 |
Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Carbamates; Diabetes Mellitus; | 1996 |
24 other studies available for carbamates and Diabetes Mellitus
| Article | Year |
|---|---|
Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports.
Topics: Benzamides; Carbamates; Diabetes Mellitus; Humans; Hypoglycemic Agents; Iran; Mutation; Piperidines | 2021 |
Repaglinide-laden hydrogel particles of xanthan gum derivatives for the management of diabetes.
Topics: Blood Glucose; Carbamates; Diabetes Mellitus; Humans; Hydrogels; Piperidines; Polysaccharides, Bacte | 2022 |
Effects on metabolic parameters in young rats born with low birth weight after exposure to a mixture of pesticides.
Topics: 2-Methyl-4-chlorophenoxyacetic Acid; Adipose Tissue; Animals; Butyrates; Carbamates; Diabetes Mellit | 2018 |
Sofosbuvir Causing Diabetes Mellitus: Is there a Link?
Topics: Antiviral Agents; Benzimidazoles; Blood Glucose; Carbamates; Diabetes Mellitus; Drug Therapy, Combin | 2018 |
MALDI-TOF mass spectrometry-based quantification of C-peptide in diabetes patients.
Topics: Aminoquinolines; Antibodies, Immobilized; C-Peptide; Carbamates; Diabetes Mellitus; Humans; Limit of | 2020 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carba | 2013 |
Drug-induced hypoglycaemia.
Topics: Anti-Bacterial Agents; Blood Glucose; Carbamates; Dextropropoxyphene; Diabetes Mellitus; Disopyramid | 2009 |
Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
Topics: Aged; Anti-Infective Agents, Urinary; Blood Glucose; Carbamates; Diabetes Complications; Diabetes Me | 2010 |
[Electrocardiographic score: application in exercise test for the assessment of ischemic preconditioning].
Topics: Carbamates; Diabetes Mellitus; Double-Blind Method; Electrocardiography; Ergometry; Female; Humans; | 2010 |
From evidence assessments to coverage decisions?: the case example of glinides in Germany.
Topics: Carbamates; Cost Control; Cost-Benefit Analysis; Costs and Cost Analysis; Cyclohexanes; Diabetes Mel | 2012 |
Amelioration of compound 4,4'-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway.
Topics: Carbamates; Cell Line; Cell Movement; Coculture Techniques; Diabetes Mellitus; Endothelium, Vascular | 2013 |
[Differences between oral antidiabetics].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Glipizide; Humans; Hypoglycemic A | 2003 |
MEBUTAMATE AND HYDROCHLOROTHIAZIDE IN HYPERTENSION.
Topics: Antihypertensive Agents; Arthritis; Arthritis, Rheumatoid; Blood Pressure Determination; Carbamates; | 1964 |
Carbamylation of hemoglobin in renal failure and clinical aspects.
Topics: Blood Urea Nitrogen; Carbamates; Cyanates; Diabetes Mellitus; Erythrocytes; Glucose Tolerance Test; | 1984 |
Pharmacologic management of diabetes mellitus.
Topics: Carbamates; Chromans; Diabetes Mellitus; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfon | 1999 |
[Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients].
Topics: Blood Glucose; Carbamates; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dose-Response Relationship, | 2000 |
Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
Topics: Adult; Blood Glucose; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Female; Food; Humans; Hypoglyc | 2001 |
[Effect of anginine on the state of the stomach and pancreas in diabetes mellitus].
Topics: Adolescent; Adult; Aged; Capillaries; Carbamates; Diabetes Mellitus; Gastric Mucosa; Humans; Middle | 1975 |
Effects of streptozotocin on carbohydrate and lipid metabolism in the rat.
Topics: Acetoacetates; Animals; Antibiotics, Antineoplastic; Blood Glucose; Carbamates; Diabetes Mellitus; D | 1971 |
Hepatic carbamyl phosphate: glucose phosphotransferase. Distribution, comparative kinetics, and responses to alloxan- or mannoheptulose-induced diabetes.
Topics: Amphibians; Animals; Astacoidea; Birds; Carbamates; Catalysis; Cats; Cattle; Diabetes Mellitus; Diab | 1972 |
[Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
Topics: Adult; Aged; Carbamates; Diabetes Mellitus; Female; Glycoproteins; Humans; Male; Middle Aged; Pyridi | 1973 |
Potential antidiabetics. XII. N- 1 -phenylcarbamoyl-4-arylazo(3- and-or 5-substituted) pyrazoles and their biological activities.
Topics: Animals; Azo Compounds; Blood Glucose; Carbamates; Diabetes Mellitus; Hypoglycemic Agents; Infrared | 1972 |
Oxidation and phosphorylation in live mitochondria from alloxan and steptozotocin diabetic rats.
Topics: Animals; Carbamates; Diabetes Mellitus; Diabetes Mellitus, Experimental; Glucosamine; Glutarates; Ma | 1971 |
Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin.
Topics: Animals; Blood Glucose; Carbamates; Carbohydrate Metabolism; Diabetes Mellitus; Diabetes Mellitus, E | 1971 |